Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

Journal of Neurology

Volumn 260, Issue 1, 2013, Pages 228-236

  Martinez Martin, Pablo ^a   Rodriguez Blazquez, Carmen ^a   Alvarez Sanchez, Mario ^b   Arakaki, Tomoko ^c   Bergareche Yarza, Alberto ^d   Chade, Anabel ^e   Garretto, Nelida ^c   Gershanik, Oscar ^e   Kurtis, Monica M ^f   Martinez Castrillo, Juan Carlos ^g   Mendoza Rodriguez, Amelia ^h   Moore, Henry P ⁱ   Rodriguez Violante, Mayela ^j   Singer, Carlos ⁱ   Tilley, Barbara C ^k   Huang, Jing ^k   Stebbins, Glenn T ^l   Goetz, Christopher G ^l  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^c HOSPITAL RAMOS MEJÍA   (Argentina)

^d HOSPITAL DONOSTIA   (Spain)

^e FAVALORO UNIVERSITY   (Argentina)

^f HOSPITAL RUBER INTERNACIONAL   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h Hospital Complejo Asistencial de Segovia   (Spain)

ⁱ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^j NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^k UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^l RUSH UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Clinimetrics; MDS UPDRS; Parkinson's disease; Rating scales; Validation

Indexed keywords

AMANTADINE; APOMORPHINE; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; RASAGILINE; SELEGILINE;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONVERGENT VALIDITY; FEMALE; HUMAN; INTERNAL VALIDITY; LANGUAGE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MOVEMENT DISORDER SOCIETY; NEUROSURGERY; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; OBSERVATION; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL;

EID: 84872358356     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6624-1     Document Type: Article

References (41)

1. Chaudhuri KR, Healy D, Schapira AHV (2006) The non-motor symptoms of Parkinson's disease. Diagnosis and management. Lancet Neurol 5:235-245. doi: 10.1016/S1474-4422(06)70373-8
2. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease, vol 2. Macmillan Healthcare Information, Florham Park, pp 153-164
3. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2003) The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18:738-750. doi: 10.1002/mds.10473
4. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT et al (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format and clinimetric testing plan. Mov Disord 22:41-47. doi: 10.1002/mds.21198
5. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129-2170. doi: 10.1002/mds.22340
6. Nunnally JC, Bernstein IH (1994) Psychometric theory. McGraw-Hill, New York
7. Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752. doi: 10.1136/jnnp.51.6.745
8. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427-442. doi: 10.1212/WNL.17.5.427
9. Martínez Martín P (2004) Valoración de la deficiencia y discapacidad en la enfermedad de Parkinson. In: Grandas F, Obeso JA, Tolosa E (eds) Tratado sobre la Enfermedad de Parkinson, 3Â Edición. Madrid: Luzán 5 S.A., pp 289-319
10. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 22:1901-1911. doi: 10.1002/mds.21596
11. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ et al (2009) International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease. Neurology 73:1584-1591. doi: 10.1212/WNL.0b013e3181c0d416
12. Martinez-Martin P, Forjaz MJ, Cubo E, Frades B, de Pedro Cuesta J, ELEP Project Members (2006) Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD). Mov Disord 21:208-214. doi: 10.1002/mds.20697
13. Martínez-Martín P, Rodríguez-Blázquez C, Forjaz MJ, de Pedro J, On behalf of the Spanish-American Longitudinal PD Patient Study Group (2009) The Clinical Impression of Severity Index for Parkinson's disease: International Validation Study. Mov Disord 24:211-217. doi: 10.1002/mds.22320
14. EuroQol Group (1990) EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16:199-208. doi: 10.1016/0168-8510(90)90421-9
15. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The PDQ-8: development and validation of a short-form Parkinson's disease Questionnaire. Psychol Health 12:805-814. doi: 10.1080/08870449708406741
16. Goetz CG, Poewe W, Rascol O et al (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020-1028. doi: 10.1002/mds.20213
17. Martínez-Martín P, Forjaz MJ, Frades B, Cubo E, de Pedro J (2005) La Rapid Assessment Disability Scale (RAD) en Enfermedad de Parkinson. Gac Sanit 19(Suppl 1):68
18. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ (2004) Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 8(9):21. doi: 10.3310/hta8090
19. Shrive FM, Stuart H, Quan H, Ghali WA (2006) Dealing with missing data in a multi-question depression scale: a comparison of imputation methods. BMC Med Res Methodol 6:57. doi: 10.1186/1471-2288-6-57
20. McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4:293-307. doi: 10.1007/BF01593882
21. Hays RD, Anderson R, Revicki D (1993) Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 6:441-449. doi: 10.1007/BF00422218
22. Scientific Advisory Committee of the Medical Outcomes Trust (2002) Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11:193-205. doi: 10.1023/A:1015291021312
23. Eisen M, Ware JE Jr, Donald CA, Brook RH (1979) Measuring components of children's health status. Med Care 17:902-921
24. Fitzpatrick R, Davey C, Buxton MJ, Jones DR (1998) Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assessm 2(14):19-43. doi: 10.3310/hta2140
25. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A (2001) The Multiple Sclerosis Impact Scale (MSIS-29). A new patient-based outcome measure. Brain 124:962-973. doi: 10.1093/brain/124.5.962
26. Fayers PM, Machin D (2000) Quality of Life. Assessment, analysis and interpretation. Wiley, Chichester, pp 45-71
27. Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T, The Clinical Significance Consensus Meeting Group (2005) Estimating clinically significant differences in quality of life outcomes. Qual Life Res 14:285-295. doi: 10.1007/s11136-004-0705-2
28. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159-174
29. Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, Bouter LM, de Vet HC (2010) The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 10:22. doi: 10.1186/1471-2288-10-22
30. Martínez-Martín P, Forjaz MJ (2006) Metric attributes of the UPDRS 3.0 battery. Part I: feasibility, scaling assumptions, reliability, and precision. Mov Disord 21:1182-1188. doi: 10.1002/mds.20916
31. Martinez-Martin P, Gil-Nagel A, Morlán Gracia L, Balseiro Gómez J, Martinez Sarriés J, Bermejo F et al (1994) Unified Parkinson's Disease Rating Scale characteristics and structure. Mov Disord 9:76-83. doi: 10.1002/mds.870090112
32. Marinus J, Visser M, Stiggelbout AM, Martin Rabey J, Martinez-Martin P, Bonuccelli U et al (2004) A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 75:388-395. doi: 10.1136/jnnp.2003.017509
33. Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I et al (2002) Test-retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: results from a multicenter clinical trial. Mov Disord 17:758-763. doi: 10.1002/mds.10011
34. Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A (2012) Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Mov Disord 27:79-83. doi: 10.1002/mds.23939
35. Forjaz MJ, Martinez-Martin P (2006) Metric attributes of the UPDRS 3.0 battery. Part II: construct and content validity. Mov Disord 21:1892-1898. doi: 10.1002/mds.21071
36. Terwee CB, Roorda LD, Knol DL, De Boer MR, De Vet HCW (2009) Linking measurement error to minimal important change of patient-reported outcomes. J Clin Epidemiol 62:1062-1067. doi: 10.1016/j.jclinepi.2008.10.011
37. Beckerman H, Roebroeck ME, Lankhorst GJ, Becher JG, Bezemer PD, Verbeek AL (2001) Smallest real difference, a link between reproducibility and responsiveness. Qual Life Res 10:571-578. doi: 10.1023/A:1013138911638
38. Rejas J, Pardo A, Ruiz MA (2008) Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcomes measures. J Clin Epidemiol 61:350-356. doi: 10.1016/j.jclinepi.2007.05.011
39. Grove A, Amante PG, Quarterman P, Wild D (2000) The translation and cross-cultural adaptation of quality-of-life measures. In: Jenkinson C, Fitzpatrick R, Jenkinson D (eds) Health status measurement in neurological disorders. Radcliffe Medical Press, Oxon, pp 161-190
40. Masur H (2004) Scales and scores in neurology. Thieme, Stuttgart, pp 4-51
41. McDowell I (2006) Measuring health. A guide to rating scales and questionnaires, 3rd edn. Oxford University Press, Oxford, pp 3-54